Skip to main content

Jennifer Shiunroh Li, MD

Beverly C. Morgan, M.D., Professor of Pediatric Cardiology in the School of Medicine
Professor of Pediatrics
Chief, Division of Pediatric Cardiology
Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail: 1927C Childrens Hlth Ctr, Box 3090, Durham, NC 27710
Phone: (919) 684-3574
Email address: li000001@mc.duke.edu

1. Pediatric hypertension and hyperlipidemia
2. Clinical trials in children with heart disease
3. Thrombosis in patients with congenital heart disease
4. Enzyme replacement in Pompe disease
5. Infective endocarditis

Education and Training

  • M.D., Duke University, 1987

Selected Grants and Awards

Publications

Pina, Liza Miriam, Xiangwen Dong, Liping Zhang, Mahesh N. Samtani, Alan D. Michelson, Henri Justino, Damien Bonnet, et al. “Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post-Fontan procedure: Rationale and design of a prospective, randomized trial (the UNIVERSE study)..” Am Heart J 213 (July 2019): 97–104. https://doi.org/10.1016/j.ahj.2019.04.009.

Full Text

Taylor-Zapata, Perdita, Carissa M. Baker-Smith, Gilbert Burckart, Stephen R. Daniels, Joseph T. Flynn, George Giacoia, Dionna Green, et al. “Research Gaps in Primary Pediatric Hypertension..” Pediatrics 143, no. 5 (May 2019). https://doi.org/10.1542/peds.2018-3517.

Full Text

Goldstone, Andrew B., Michael Baiocchi, David Wypij, Christian Stopp, Dean B. Andropoulos, Joseph Atallah, Andrew M. Atz, et al. “The Bayley-III scale may underestimate neurodevelopmental disability after cardiac surgery in infants†..” Eur J Cardiothorac Surg, April 21, 2019. https://doi.org/10.1093/ejcts/ezz123.

Full Text

McCrary, Andrew W., Piers C. A. Barker, Rachel D. Torok, Tracy G. Spears, Jennifer S. Li, Christoph P. Hornik, and Matthew M. Laughon. “Agreement of an echocardiogram-based diagnosis of pulmonary hypertension in infants at risk for bronchopulmonary dysplasia among masked reviewers..” J Perinatol 39, no. 2 (February 2019): 248–55. https://doi.org/10.1038/s41372-018-0277-6.

Full Text

Handisides, Jill C., Danielle Hollenbeck-Pringle, Karen Uzark, Felicia L. Trachtenberg, Victoria L. Pemberton, Teresa W. Atz, Timothy J. Bradley, et al. “Health-Related Quality of Life in Children and Young Adults with Marfan Syndrome..” J Pediatr 204 (January 2019): 250-255.e1. https://doi.org/10.1016/j.jpeds.2018.08.061.

Full Text

Hoskoppal, Arvind, Shaji Menon, Felicia Trachtenberg, Kristin M. Burns, Julie De Backer, Bruce D. Gelb, Marie Gleason, et al. “Predictors of Rapid Aortic Root Dilation and Referral for Aortic Surgery in Marfan Syndrome..” Pediatr Cardiol 39, no. 7 (October 2018): 1453–61. https://doi.org/10.1007/s00246-018-1916-6.

Full Text

Herbert, Mrudu, Heidi Cope, Jennifer S. Li, and Priya S. Kishnani. “G Variant: Implications for Newborn Screening..” J Pediatr 198 (July 2018): 308–12. https://doi.org/10.1016/j.jpeds.2018.02.007.

Full Text

Newburger, Jane W., Lynn A. Sleeper, J William Gaynor, Danielle Hollenbeck-Pringle, Peter C. Frommelt, Jennifer S. Li, William T. Mahle, et al. “Transplant-Free Survival and Interventions at 6 Years in the SVR Trial..” In Circulation, 137:2246–53, 2018. https://doi.org/10.1161/CIRCULATIONAHA.117.029375.

Full Text

Torok, Rachel D., Jennifer S. Li, Prince J. Kannankeril, Andrew M. Atz, Raafat Bishai, Ellen Bolotin, Stefanie Breitenstein, et al. “Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank..” J Am Heart Assoc 7, no. 4 (February 10, 2018). https://doi.org/10.1161/JAHA.117.007283.

Full Text

Hill, K. D., R. D. Török, R. J. Portman, and J. S. Li. “Changes in drug development regulations and their impact on clinical trials.” In Pediatric Hypertension, 841–52, 2018. https://doi.org/10.1007/978-3-319-31107-4_38.

Full Text

Pages